CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Egros Fabrice Director | Sale | −10,167 | $24.31 | $247K | 16,074 |
| 2021-03-01 | Egros Fabrice Director | Sale | −74 | $24.31 | $2K | 16,000 |
| 2021-03-01 | Egros Fabrice Director | Option exercise · Stock Options (Right to buy) | −74 | 0 | ||
| 2021-03-01 | Egros Fabrice Director | Option exercise · Stock Options (Right to buy) | −10,167 | 0 | ||
| 2021-02-08 | Morrison Briggs Chief Executive Officer | Option exercise | +35,156 | $7.20 | $253K | 83,492 |
| 2021-02-08 | Morrison Briggs Chief Executive Officer | Sale | −35,156 | $20.55 | $722K | 48,336 |
| 2021-02-08 | Morrison Briggs Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −35,156 | 0 | ||
| 2021-02-03 | Metzger Michael A President and COO | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-02-03 | Ordentlich Peter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-02-03 | Karydas Daphne Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2021-02-03 | Morrison Briggs Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2021-02-03 | Meyers Michael L. SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-02-03 | Podlesak Dennis Director | Grant or award | +29,333 | 29,333 | ||
| 2021-02-03 | Meury William Director | Grant or award | +16,000 | 16,000 | ||
| 2021-02-03 | Legault Pierre Director | Grant or award | +16,000 | 16,000 | ||
| 2021-02-03 | Katkin Keith Director | Grant or award | +16,000 | 16,000 | ||
| 2021-02-03 | Jarrett Jennifer Director | Grant or award | +16,000 | 16,000 | ||
| 2021-02-03 | Egros Fabrice Director | Grant or award | +16,000 | 16,000 | ||
| 2021-02-01 | Metzger Michael A President and COO | Option exercise | +15,000 | $7.20 | $108K | 32,659 |
| 2021-02-01 | Metzger Michael A President and COO | Sale | −15,000 | $20.19 | $303K | 17,659 |
Page 20 of 25 · 500 trades